Devices, systems, and methods for non-volatile storage include a well activation device operable to modify one or more wells from a plurality of wells of a flow cell to provide a set of readable wells. Readable wells are configured to allow exposure of a well to substances from nucleotide sequencing fluids, and prevent exposure to other substances and fluids, such as nucleotide synthesizing fluids. The well activation device may also modify wells to provide a set of writeable wells. This set of wells is configured to allow exposure to the nucleotide synthesizing fluids and substances; and prevent exposure to the nucleotide sequencing fluids and substances. There may also be provisions made for risk mitigation for data errors such as generating commands to write specified data to a nucleotide sequence associated with a particular location in a storage device, reading the nucleotide sequence and performing a comparison.

Devices, systems, and methods for non-volatile storage include a well activation device operable to modify one or more wells from a plurality of wells of a flow cell to provide a set of readable wells. Readable wells are configured to allow exposure of a well to substances from nucleotide sequencing fluids, and prevent exposure to other substances and fluids, such as nucleotide synthesizing fluids. The well activation device may also modify wells to provide a set of writeable wells. This set of wells is configured to allow exposure to the nucleotide synthesizing fluids and substances; and prevent exposure to the nucleotide sequencing fluids and substances. There may also be provisions made for risk mitigation for data errors such as generating commands to write specified data to a nucleotide sequence associated with a particular location in a storage device, reading the nucleotide sequence and performing a comparison.

Determining relative relationships of people who share a common ancestor within at least a threshold number of generations includes: receiving recombinable deoxyribonucleic acid (DNA) sequence information of a first user and recombinable DNA sequence information of a plurality of users; processing, using one or more computer processors, the recombinable DNA sequence information of the plurality of users in parallel; determining, based at least in part on a result of processing the recombinable DNA information of the plurality of users in parallel, a predicted degree of relationship between the first user and a user among the plurality of users, the predicted degree of relative relationship corresponding to a number of generations within which the first user and the second user share a common ancestor.

Determining relative relationships of people who share a common ancestor within at least a threshold number of generations includes: receiving recombinable deoxyribonucleic acid (DNA) sequence information of a first user and recombinable DNA sequence information of a plurality of users; processing, using one or more computer processors, the recombinable DNA sequence information of the plurality of users in parallel; determining, based at least in part on a result of processing the recombinable DNA information of the plurality of users in parallel, a predicted degree of relationship between the first user and a user among the plurality of users, the predicted degree of relative relationship corresponding to a number of generations within which the first user and the second user share a common ancestor.

The subject matter presently claimed relates to a data quality management system and method whereby a first data point comprising a first obtained data and a first assigned value from is received from a first data repository, a first quality score as well as a first storable data of the first data point is determined and/or stored. A second data point comprising a second obtained data, which is similar to the first obtained data according to a predefined similarity measure, and a second assigned value is received from the second data repository, a second quality score as well as a second storable data is determined from the second data point and/or stored and a second transmittable data, determined from the second data point and/or the second quality score is transmitted to the first data repository, causing the first data repository to re-evaluate the first assigned value.

The subject matter presently claimed relates to a data quality management system and method whereby a first data point comprising a first obtained data and a first assigned value from is received from a first data repository, a first quality score as well as a first storable data of the first data point is determined and/or stored. A second data point comprising a second obtained data, which is similar to the first obtained data according to a predefined similarity measure, and a second assigned value is received from the second data repository, a second quality score as well as a second storable data is determined from the second data point and/or stored and a second transmittable data, determined from the second data point and/or the second quality score is transmitted to the first data repository, causing the first data repository to re-evaluate the first assigned value.

A storage medium storing a diagnosis support program that causes at least one computer to execute a process that includes acquiring a set of rules, the rules being represented by a combination of features and generated by machine learning by using a training data set, the training data set including a feature indicated by a sample as a diagnosis target and a feature indicated by a sample as a non-diagnosis target, each of the set of rules being associated with a first weight for the diagnosis target; determining, for each of plurality of patterns each of that includes a certain number of features, a second weight based on the first weight associated with a rule that includes the feature included in the pattern among the rules; and outputting a pattern with the second weight that is equal to or greater than a certain value among the plurality of patterns.

A storage medium storing a diagnosis support program that causes at least one computer to execute a process that includes acquiring a set of rules, the rules being represented by a combination of features and generated by machine learning by using a training data set, the training data set including a feature indicated by a sample as a diagnosis target and a feature indicated by a sample as a non-diagnosis target, each of the set of rules being associated with a first weight for the diagnosis target; determining, for each of plurality of patterns each of that includes a certain number of features, a second weight based on the first weight associated with a rule that includes the feature included in the pattern among the rules; and outputting a pattern with the second weight that is equal to or greater than a certain value among the plurality of patterns.

The present invention relates to a driving method of a block chain-based health data management system. When personal health data such as health examination or prescription data and the like is uploaded, a genome portal: stores the personal health data as metadata together with genetic information; provides the personal health data so that a demand agency requiring the personal health data can use Zerocoin to purchase or read the personal health data through the genome portal; provides rewards in the form of mileage to individuals who share the data in the genome portal; ranks the individuals by the number of times the individuals have shared the data; automatically presents various personalized health solutions in the portal through AI according to the shared data; provides a rapidly growing personal genome prediction/diagnosis service through a portal system by using a blockchain-based MS decentralized identity (DID) in order to enhance the security of the email addresses and IDs of users; and ascribes value to personal health big data, such as genome data, medical diagnosis information, or social data, and so as to reduce the costs of personal genetic testing and diagnosis.

A method for treating cancer by treating target cancer cells with cold atmospheric plasma to induce apoptosis of the target cancer cells through the degradation of Histone RNA during S-phase induced by oxidation of RNA.